Company intelligence / Profile preview

Stendhal Pharma

Tlalpan, CDMX, Mexicostendhalpharma.com ↗

Ownership: Private
Employees: ~224
Development stage: Commercial

Overview

Stendhal Pharma develops and markets innovative pharmaceutical products with a focus on high specialty medicines and orphan drugs. The company has a robust presence in Latin America with ongoing product launches—recently including an antibiotic for ABSSI—and strategic partnerships to expand its portfolio. It emphasizes sustainability and ethical business practices while investing in medical teams to support growth. Clinical results are not detailed publicly.

Therapeutic areas: CardiovascularRare DiseasesNeurologyInfectious Diseases
Modalities: Small molecules
Industry: Biotech

Partnerships

Adalvo (antibiotic co-development/commercialization partnership)

Beyond the preview

Go deeper on Stendhal Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stendhal Pharma.